Dominique Schols

Q: What Schools Are Affiliated With Dominique Schols

Dominique Schols is affiliated with the following schools: University of Amsterdam, KU Leuven

Dominique Schols's AcademicInfluence.com Rankings

Dominique Schols

Computer Science

#5186

World Rank

#5480

Historical Rank

Artificial Intelligence

#1512

World Rank

#1541

Historical Rank

Database

#2333

World Rank

#2448

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Dominique Schols's Degrees

PhD Computer Science University of Amsterdam
Masters Artificial Intelligence University of Amsterdam
Bachelors Computer Science University of Amsterdam

Similar Degrees You Can Earn

Why Is Dominique Schols Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dominique Schols's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. (1988) (1518)
CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity (2001) (981)
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor (1998) (765)
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives (1990) (669)
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4 (1997) (575)
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4 (2002) (465)
Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection (2004) (353)
Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine (1993) (329)
Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity (2001) (290)
AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-γ Receptor-Deficient Mice1 (2001) (271)
Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV (1998) (270)
Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative. (1989) (269)
The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model (2016) (251)
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents (1988) (245)
The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. (1992) (239)
AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. (2002) (236)
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. (1992) (232)
Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro (1991) (224)
Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. (1997) (223)
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells (2010) (212)
Processing by CD26/dipeptidyl‐peptidase IV reduces the chemotactic and anti‐HIV‐1 activity of stromal‐cell‐derived factor‐1α (1998) (207)
Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. (1990) (198)
CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization. (2010) (196)
Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying Anti-HIV Activity (2018) (182)
CXCR4 as a Functional Coreceptor for Human Immunodeficiency Virus Type 1 Infection of Primary Macrophages (1998) (180)
Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. (1988) (179)
Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors (2008) (179)
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters (2020) (173)
Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. (1992) (167)
Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase. (1993) (162)
HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. (2000) (161)
HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. (2001) (161)
CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. (1999) (160)
Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle. (2000) (157)
Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction* (1999) (155)
Antiviral agents active against human herpesviruses HHV‐6, HHV‐7 and HHV‐8 (2001) (151)
Determinants for Sensitivity of Human Immunodeficiency Virus Coreceptor CXCR4 to the Bicyclam AMD3100 (1998) (151)
In Vivo Evolution of Human Immunodeficiency Virus Type 1 toward Increased Pathogenicity through CXCR4-Mediated Killing of Uninfected CD4 T Cells (2003) (147)
Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection (2004) (147)
Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. (2012) (144)
2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase. (1992) (143)
Role of CXCR4 in Cell-Cell Fusion and Infection of Monocyte-Derived Macrophages by Primary Human Immunodeficiency Virus Type 1 (HIV-1) Strains: Two Distinct Mechanisms of HIV-1 Dual Tropism (1999) (130)
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate (2020) (120)
Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide. (2011) (120)
Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras (1994) (119)
AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor. (2005) (116)
Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir). (1998) (116)
Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. (1999) (115)
Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120 (2005) (114)
Shift of Clinical Human Immunodeficiency Virus Type 1 Isolates from X4 to R5 and Prevention of Emergence of the Syncytium-Inducing Phenotype by Blockade of CXCR4 (1999) (114)
The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications (2013) (114)
T-Cell-Line-Tropic Human Immunodeficiency Virus Type 1 That Is Made Resistant to Stromal Cell-Derived Factor 1α Contains Mutations in the Envelope gp120 but Does Not Show a Switch in Coreceptor Use (1998) (113)
Molecular Mechanism of Action of Monocyclam Versus Bicyclam Non-peptide Antagonists in the CXCR4 Chemokine Receptor* (2007) (111)
Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters. (2000) (109)
Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation (1990) (109)
Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. (1989) (107)
Investigation of Griffithsin's Interactions with Human Cells Confirms Its Outstanding Safety and Efficacy Profile as a Microbicide Candidate (2011) (107)
Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. (1999) (107)
Diverging binding capacities of natural LD78β isoforms of macrophage inflammatory protein‐1α to the CC chemokine receptors 1, 3 and 5 affect their anti‐HIV‐1 activity and chemotactic potencies for neutrophils and eosinophils (2001) (107)
Microvirin, a Novel α(1,2)-Mannose-specific Lectin Isolated from Microcystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile* (2010) (106)
Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100. (2001) (105)
Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. (1998) (104)
Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis (2005) (104)
The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. (1999) (103)
Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG). (1990) (102)
The role of CD26/DPP IV in chemokine processing. (1999) (101)
Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production (1996) (100)
Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes (2006) (99)
Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins (2004) (97)
Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor. (1999) (97)
Citrullination of CXCL12 Differentially Reduces CXCR4 and CXCR7 Binding with Loss of Inflammatory and Anti-HIV-1 Activity via CXCR41 (2009) (97)
Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus (2006) (93)
Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. (2001) (93)
Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication. (2010) (92)
Flow cytometric method to demonstrate whether anti-HIV-1 agents inhibit virion binding to T4+ cells. (1989) (89)
Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4. (1999) (87)
Lymphoid and myeloid differentiation of fetal liver CD34+lineage- cells in human thymic organ culture (1994) (86)
Interleukin-8 and Growth-Regulated Oncogene Alpha Mediate Angiogenesis in Kaposi's Sarcoma (2002) (85)
Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein. (1997) (84)
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. (1992) (84)
A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry. (2000) (82)
Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight. (1991) (80)
Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral action. (2005) (80)
Inhibition of Human Immunodeficiency Virus Replication by a Dual CCR5/CXCR4 Antagonist (2004) (80)
Carbohydrate-Binding Agents Efficiently Prevent Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin (DC-SIGN)-Directed HIV-1 Transmission to T Lymphocytes (2007) (79)
Sulphated Polymers are Potent and Selective Inhibitors of Various Enveloped Viruses, Including Herpes Simplex Virus, Cytomegalovirus, Vesicular Stomatitis Virus, Respiratory Syncytial Virus, and Toga-, Arena- and Retroviruses (1990) (78)
Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity (2015) (78)
Viral Entry through CXCR4 Is a Pathogenic Factor and Therapeutic Target in Human Immunodeficiency Virus Type 1 Disease (2000) (78)
CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro (2004) (78)
Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent. (2008) (78)
Bicyclams, Selective Antagonists of the Human Chemokine Receptor CXCR4, Potently Inhibit Feline Immunodeficiency Virus Replication (1999) (77)
A Derivate of the Antibiotic Doxorubicin Is a Selective Inhibitor of Dengue and Yellow Fever Virus Replication In Vitro (2010) (76)
Apoptosis of Bystander T Cells Induced by Human Immunodeficiency Virus Type 1 with Increased Envelope/Receptor Affinity and Coreceptor Binding Site Exposure (2004) (74)
Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein. (1999) (74)
CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity. (1998) (73)
Algal Lectins as Potential HIV Microbicide Candidates (2012) (73)
CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor. (2002) (71)
Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions. (2007) (70)
Evaluation of SDF‐1/CXCR4‐induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry (2003) (68)
Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity. (1990) (68)
Marked Depletion of Glycosylation Sites in HIV-1 gp120 under Selection Pressure by the Mannose-Specific Plant Lectins of Hippeastrum Hybrid and Galanthus nivalis (2005) (67)
Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles. (2010) (66)
Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins. (1991) (65)
Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis. (1992) (64)
Identification of a Subset of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus Strains Able To Exploit an Alternative Coreceptor on Untransformed Human Brain and Lymphoid Cells (2003) (63)
Dengue Virus Entry as Target for Antiviral Therapy (2012) (62)
Lectin-Like Molecules of Lactobacillus rhamnosus GG Inhibit Pathogenic Escherichia coli and Salmonella Biofilm Formation (2016) (62)
Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors. (1992) (61)
HIV co-receptors as targets for antiviral therapy. (2004) (61)
A Human Immunodeficiency Virus Type 1 Isolate from an Infected Person Homozygous for CCR5Δ32 Exhibits Dual Tropism by Infecting Macrophages and MT2 Cells via CXCR4 (2002) (60)
The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor. (2003) (60)
ACYCLIC/CARBOCYCLIC GUANOSINE ANALOGUES AS ANTI-HERPESVIRUS AGENTS (2001) (60)
New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs (1994) (59)
Viral Interactions in Human Lymphoid Tissue: Human Herpesvirus 7 Suppresses the Replication of CCR5-Tropic Human Immunodeficiency Virus Type 1 via CD4 Modulation (2006) (58)
Broad Antiviral Activity of Carbohydrate-Binding Agents against the Four Serotypes of Dengue Virus in Monocyte-Derived Dendritic Cells (2011) (58)
Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action. (2000) (58)
Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity. (1993) (58)
Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope (2010) (56)
Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. (2009) (56)
Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. (2001) (55)
Sugar-Binding Proteins Potently Inhibit Dendritic Cell Human Immunodeficiency Virus Type 1 (HIV-1) Infection and Dendritic-Cell-Directed HIV-1 Transfer (2005) (55)
Differential Cytokine, Chemokine and Growth Factor Expression in Phenotypes of Chronic Lung Allograft Dysfunction (2015) (54)
The LD78β Isoform of MIP-1α Is the Most Potent CC-Chemokine in Inhibiting CCR5-Dependent Human Immunodeficiency Virus Type 1 Replication in Human Macrophages (2001) (54)
Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes. (1991) (53)
Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication. (1996) (53)
Antiviral Activity of low-MW Dextran Sulphate (Derived from dextran MW 1000) Compared to Dextran Sulphate Samples of Higher MW (1991) (52)
Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds. (1991) (51)
Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C. (2011) (51)
Mechanisms underlying activity of antiretroviral drugs in HIV‐1‐infected macrophages: new therapeutic strategies (2006) (51)
The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications (2015) (49)
In Vivo Evolution of X4 Human Immunodeficiency Virus Type 1 Variants in the Natural Course of Infection Coincides with Decreasing Sensitivity to CXCR4 Antagonists (2004) (48)
Lipophilic prodrugs of nucleoside triphosphates as biochemical probes and potential antivirals (2015) (48)
Selective activity of various antiviral compounds against HHV-7 infection. (1999) (48)
HIV chemokine receptor inhibitors as novel anti-HIV drugs. (2005) (48)
New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors. (2012) (48)
Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication. (2010) (48)
Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission. (1998) (47)
Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists (2004) (47)
The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells. (1998) (47)
Impact of Cytokines on Replication in the Thymus of Primary Human Immunodeficiency Virus Type 1 Isolates from Infants (2002) (46)
Differential antiviral activity of derivatized dextrans. (1995) (46)
Therapeutic strategies towards HIV-1 infection in macrophages. (2006) (46)
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters (2020) (45)
Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. (1988) (45)
Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains. (2012) (44)
Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation (2016) (44)
Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties. (2016) (44)
CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual‐tropic (R5/X4) HIV‐1 infection (2011) (44)
Lectin-Glycan Interaction Network-Based Identification of Host Receptors of Microbial Pathogenic Adhesins (2016) (44)
IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist. (1995) (44)
RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE) (1997) (43)
Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry. (1989) (43)
Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. (2007) (43)
DC-SIGN Increases the Affinity of HIV-1 Envelope Glycoprotein Interaction with CD4 (2011) (43)
Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use (2010) (42)
Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model (2017) (42)
The candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1. (2009) (41)
SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus (1997) (41)
Highly stable hexitol based XNA aptamers targeting the vascular endothelial growth factor (2019) (41)
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. (2002) (40)
Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3 (2017) (40)
Different Evolution of Genotypic Resistance Profiles to Emtricitabine Versus Lamivudine in Tenofovir-Containing Regimens (2010) (40)
Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication. (1993) (40)
HIV co-receptor inhibitors as novel class of anti-HIV drugs. (2006) (40)
Signal Peptide-Binding Drug as a Selective Inhibitor of Co-Translational Protein Translocation (2014) (40)
Total synthesis of the antiviral peptide antibiotic feglymycin. (2009) (39)
Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues. (2016) (39)
Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay. (2001) (39)
Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication. (1991) (39)
Nanobody‐Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4‐mediated HIV‐entry and induce antibody effector functions (2018) (38)
HIV-1 X4 activities of polycationic "viologen" based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationship. (2012) (38)
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes. (2008) (38)
Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies (2004) (38)
Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues. (2006) (38)
Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin family. (2014) (38)
Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor. (2011) (37)
The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor. (2012) (37)
Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes. (1992) (36)
Coreceptor Phenotype of Natural Human Immunodeficiency Virus with Nef Deleted Evolves In Vivo, Leading to Increased Virulence (2002) (36)
Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335 (1992) (36)
Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120. (2012) (36)
In vivo cytokine expression in the thymus. CD3high human thymocytes are activated and already functionally differentiated in helper and cytotoxic cells. (1994) (35)
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice (2018) (35)
Mutations at the CXCR4 interaction sites for AMD3100 influence anti‐CXCR4 antibody binding and HIV‐1 entry (2003) (35)
Sulphated Cyclodextrins are Potent anti-HIV Agents Acting Synergistically with 2′,3′-dideoxynucleoside Analogues (1991) (35)
Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors (2017) (35)
Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors. (2014) (35)
Nucleoside Diphosphate Prodrugs: Nonsymmetric DiPPro-Nucleotides. (2015) (35)
Sulfated Escherichia coli K5 Polysaccharide Derivatives Inhibit Dengue Virus Infection of Human Microvascular Endothelial Cells by Interacting with the Viral Envelope Protein E Domain III (2013) (34)
Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds. (1989) (34)
Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis. (2016) (34)
Vascular endothelial growth factor pathway in endometriosis: genetic variants and plasma biomarkers. (2016) (33)
Preparation and anti-HIV activity of O-acylated heparin and dermatan sulfate derivatives with low anticoagulant effect. (1993) (33)
Differential in vitro inhibitory activity against HIV-1 of alpha-(1-3)- and alpha-(1-6)-D-mannose specific plant lectins : Implication for microbicide development (2007) (32)
Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1. (2001) (32)
The lectin-like protein 1 in Lactobacillus rhamnosus GR-1 mediates tissue-specific adherence to vaginal epithelium and inhibits urogenital pathogens (2016) (32)
Azithromycin and the Treatment of Lymphocytic Airway Inflammation After Lung Transplantation (2014) (32)
Reduced Fitness of HIV-1 Resistant to Cxcr4 Antagonists (2003) (32)
Targeting HIV entry through interaction with envelope glycoprotein 120 (gp120): synthesis and antiviral evaluation of 1,3,5-triazines with aromatic amino acids. (2011) (32)
CXCR4‐targeting nanobodies differentially inhibit CXCR4 function and HIV entry (2018) (32)
Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection. (2012) (31)
CXCR4 chemokine receptor antagonists: nickel(II) complexes of configurationally restricted macrocycles. (2012) (31)
Human Ig production and isotype switching in severe combined immunodeficient-human mice. (1993) (30)
New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities. (2015) (30)
5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine. (1989) (30)
HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assay. (2011) (30)
A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2. (2010) (30)
Anti-HIV activity profile of AMD070, an orally bioavailable CXCR4 antagonist (2003) (30)
Anti-HIV Activities of Anionic Metalloporphyrins and Related Compounds (1997) (30)
Design, synthesis, antiviral and cytostatic activity of ω-(1H-1,2,3-triazol-1-yl)(polyhydroxy)alkylphosphonates as acyclic nucleotide analogues (2014) (30)
Detection of immediate early, early and late antigens of human cytomegalovirus by flow cytometry. (1989) (29)
Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique. (1991) (29)
2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: synthesis, cytotoxic activity and mechanism of action. (2014) (29)
Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor (2005) (29)
Study of the Chemoselectivity of Multicomponent Heterocyclizations Involving 3-Amino-1,2,4-triazole and Pyruvic Acids as Key Reagents, and Biological Activity of the Reaction Products (2015) (28)
Specific CD4 down‐modulating compounds with potent anti‐HIV activity (2003) (28)
High mannose-specific lectin Msl mediates key interactions of the vaginal Lactobacillus plantarum isolate CMPG5300 (2016) (28)
Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation. (2016) (28)
The role of N-glycosylation sites on the CXCR4 receptor for CXCL-12 binding and signaling and X4 HIV-1 viral infectivity. (2007) (27)
A highly reliable, sensitive, flow cytometric/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT-4 cells. (1988) (27)
Differential Activity of Polyanionic Compounds and Castanospermine against HIV Replication and HIV-Induced Syncytium Formation Depending on Virus Strain and Cell Type (1992) (27)
Long-Lasting Enfuvirtide Carrier Pentasaccharide Conjugates with Potent Anti-Human Immunodeficiency Virus Type 1 Activity (2009) (27)
Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infection. (1996) (27)
Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines. (2006) (27)
Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity. (2014) (27)
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate (2020) (27)
Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication. (2011) (26)
Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity (2011) (26)
New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship. (2018) (24)
Design, Synthesis, and Antiviral Activity of Novel Ribonucleosides of 1,2,3‐Triazolylbenzyl‐aminophosphonates (2015) (24)
NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles (2015) (24)
Inhibitors of HIV infection via the cellular CD4 receptor. (2006) (24)
Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication. (2011) (23)
9-(2-Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase. (1999) (23)
Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus (1991) (23)
1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2′,3′-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes (1991) (23)
Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza (2021) (23)
Polysulfonates Derived from Metal Thiolate Complexes as Inhibitors of HIV-1 and Various other Enveloped Viruses In Vitro (2002) (22)
Design, Synthesis and Biological Evaluation of Novel Primaquine-Cinnamic Acid Conjugates of the Amide and Acylsemicarbazide Type (2016) (22)
Design, antiviral and cytostatic properties of isoxazolidine-containing amonafide analogues (2015) (22)
Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissue. (2001) (22)
Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs. (2005) (21)
Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents. (1992) (21)
Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration. (1995) (20)
CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor. (2008) (20)
Synthesis of different types of alkoxy fullerene derivatives from chlorofullerene C60Cl6. (2017) (20)
Prone Positioning During Ex Vivo Lung Perfusion Influences Regional Edema Accumulation. (2019) (20)
Synthesis, anti-varicella-zoster virus and anti-cytomegalovirus activity of quinazoline-2,4-diones containing isoxazolidine and phosphonate substructures (2016) (20)
Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120. (2012) (20)
Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1. (1999) (19)
Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs). (2011) (19)
Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated Virolysis (2019) (19)
Agonist-Induced Internalization of CC Chemokine Receptor 5 as a Mechanism to Inhibit HIV Replication (2011) (18)
Immunocytochemical demonstration of proopiomelanocortin- and other opioid-related substances and a CRF-like peptide in the gut of the american cockroach, Periplaneta americana L. (2004) (18)
Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements (2017) (18)
Coreceptor usage of sequential isolates from cynomolgus monkeys experimentally Infected with simian immunodeficiency virus (SIVsm). (2001) (18)
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues (2021) (18)
CD4 down-modulating compounds with potent anti-HIV activity. (2004) (18)
Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)). (2004) (17)
Tri-armed ligands of G-quadruplex on heteroarene-fused anthraquinone scaffolds: Design, synthesis and pre-screening of biological properties. (2018) (17)
Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs. (2017) (17)
Flow cytometric method to monitor the destruction of CD4+ cells following their fusion with HIV-infected cells. (1990) (17)
Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore‐based virtual screening approach (2020) (17)
Inhibitory Effects of Polycations on the Replication of Enveloped Viruses (HIV, HSV, CMV, RSV, Influenza A Virus and Togaviruses) in vitro (1991) (17)
Structural investigation and anti-HIV activities of high molecular weight ATA polymers (1992) (17)
Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives (2019) (17)
Modified Cyclodextrin Sulphates(mCDS11) have Potent Inhibitory Activity against HIV and High Oral Bioavailability (1994) (16)
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents. (1991) (16)
New Polyacetal Polysulphate Active against Human Immunodeficiency Virus and other Enveloped Viruses (1992) (16)
Polyanion inhibitors of human immunodeficiency virus and other viruses. Part 2. Polymerized anionic surfactants derived from amino acids and dipeptides. (1996) (16)
Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies. (2016) (16)
A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice (2020) (16)
Engineering Lactobacillus rhamnosus GG and GR-1 to express HIV-inhibiting griffithsin. (2018) (16)
Anti-HIV-1 activity of antiviral compounds, as quantitated by a focal immunoassay in CD4+ HeLa cells and a plaque assay in MT-4 cells. (1990) (16)
Novel In Vivo Model for the Study of Human Immunodeficiency Virus Type 1 Transcription Inhibitors: Evaluation of New 6-Desfluoroquinolone Derivatives (2007) (16)
Alkylated benzimidazoles: Design, synthesis, docking, DFT analysis, ADMET property, molecular dynamics and activity against HIV and YFV (2020) (16)
Unsymmetrical cyclotriazadisulfonamide (CADA) compounds as human CD4 receptor down-modulating agents. (2011) (16)
Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approach. (2011) (16)
A Multi-targeted Drug Candidate with Dual Anti-HIV and Anti-HSV Activity (2013) (15)
A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA)* (2016) (15)
Combination of antiretroviral drugs as microbicides. (2012) (15)
Inhibition of human IgE synthesis in vitro and in SCID-hu mice by an interleukin-4 receptor antagonist. (1995) (15)
Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro. (1989) (15)
IL-2 reverses human T cell unresponsiveness induced by thymic epithelium in SCID-hu mice. (1994) (15)
Direct arylation of C60Cl6 and C70Cl8 with carboxylic acids: a synthetic avenue to water-soluble fullerene derivatives with promising antiviral activity. (2019) (15)
Synthesis and evaluation of the biological activity of N′-[2-oxo-1,2 dihydro-3H-indol-3-ylidene] benzohydrazides as potential anticancer agents (2015) (15)
Modest Human Immunodeficiency Virus Coreceptor Function of CXCR3 Is Strongly Enhanced by Mimicking the CXCR4 Ligand Binding Pocket in the CXCR3 Receptor (2007) (15)
Synthesis of Novel Chiral Sulfonamide-Bearing 1,2,4-Triazole-3-thione Analogs Derived from D- and L-Phenylalanine Esters as Potential Anti-Influenza Agents. (2016) (15)
Structure‐activity relationship studies on a Trp dendrimer with dual activities against HIV and enterovirus A71. Modifications on the amino acid (2017) (14)
Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4. (2003) (14)
Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency. (1999) (14)
Aspartate-Based CXCR4 Chemokine Receptor Binding of Cross-Bridged Tetraazamacrocyclic Copper(II) and Zinc(II) Complexes. (2016) (14)
Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties. (2020) (14)
Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs (2009) (14)
Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection (2008) (14)
64Cu PET Imaging of the CXCR4 Chemokine Receptor Using a Cross-Bridged Cyclam Bis-Tetraazamacrocyclic Antagonist (2020) (14)
No Selection for CCR5 Coreceptor Usage during Parenteral Transmission of Macrophagetropic Syncytium-Inducing Human Immunodeficiency Virus Type 1 (2001) (13)
Anti-HIV-active Nucleoside Triphosphate Prodrugs. (2020) (13)
Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool. (2019) (13)
Productive Infection of Primary Macrophages with Human Herpesvirus 7 (2001) (13)
A SCAFFOLD SIMPLIFICATION STRATEGY LEADS TO A NOVEL GENERATION OF DUAL HUMAN IMMUNODEFICIENCY VIRUS AND ENTEROVIRUS-A71 ENTRY INHIBITORS. (2019) (13)
Isolation and identification of naturally modified C-C chemokines MCP-1, MCP-2 and RANTES: effects of posttranslational modifications on receptor usage, chemotactic and anti-HIV-1 activity. (1998) (13)
Novel halogenated 3-deazapurine, 7-deazapurine and alkylated 9-deazapurine derivatives of l-ascorbic or imino-l-ascorbic acid: Synthesis, antitumour and antiviral activity evaluations (2015) (12)
Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins (2004) (12)
BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance. (2015) (12)
Early identification of availability issues for poorly water-soluble microbicide candidates in biorelevant media: a case study with saquinavir. (2011) (12)
New Isoxazolidine-Conjugates of Quinazolinones—Synthesis, Antiviral and Cytostatic Activity (2016) (12)
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer (2021) (12)
Human Immunodeficiency Virus Type 1 Escape from Cyclotriazadisulfonamide-Induced CD4-Targeted Entry Inhibition Is Associated with Increased Neutralizing Antibody Susceptibility (2009) (12)
Synthesis and the Biological Activity of Phosphonylated 1,2,3-Triazolenaphthalimide Conjugates (2016) (11)
4-(1-Adamantyl)phenylalkylamines with Potential Antiproliferative Activity (2016) (11)
Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity. (2007) (11)
In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070 (2004) (11)
The Phthalocyanine Prototype Derivative Alcian Blue Is the First Synthetic Agent with Selective Anti-Human Immunodeficiency Virus Activity Due to Its gp120 Glycan-Binding Potential (2009) (11)
In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20). (2009) (11)
Synthesis of a 3′-C-ethynyl-β-d-ribofuranose purine nucleoside library: Discovery of C7-deazapurine analogs as potent antiproliferative nucleosides (2018) (11)
Mechanism of the Antiviral Activity of New Aurintricarboxylic Acid Analogues (1996) (11)
Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological Findings (2022) (11)
Antiviral activity of carbohydrate-binding agents by interrupting the interaction between DC-SIGN and dengue virus (2009) (10)
Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization. (2020) (10)
Novel Isoxazolidine and γ-Lactam Analogues of Homonucleosides (2019) (10)
Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products. (2017) (10)
Griffithsin, Alone and Combined with All Classes of Antiretroviral Drugs, Potently Inhibits HIV Cell-Cell Transmission and Destruction of CD4+ T cells (2012) (10)
Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate-binding agents and polyanions. (2009) (10)
Structural analogs of umifenovir 2*. The synthesis and antiHIV activity study of new regioisomeric (trans-2-phenylcyclopropyl)-1Н-indole derivatives (2015) (10)
The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level. (2003) (10)
Aminomethylation of heliomycin: Preparation and anticancer characterization of the first series of semi-synthetic derivatives. (2018) (9)
Diversion of the Arbuzov reaction: alkylation of C-Cl instead of phosphonic ester formation on the fullerene cage. (2019) (9)
Development and Identification of a Novel Anti-HIV-1 Peptide Derived by Modification of the N-Terminal Domain of HIV-1 Integrase (2016) (9)
Preprotein signature for full susceptibility to the co‐translational translocation inhibitor cyclotriazadisulfonamide (2020) (9)
Targeted disruption of pi–pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity (2021) (9)
Bis(benzoyloxybenzyl)‐DiPPro Nucleoside Diphosphates of Anti‐HIV Active Nucleoside Analogues (2015) (9)
Simian Immunodeficiency Virus Is Susceptible to Inhibition by Carbohydrate-Binding Agents in a Manner Similar to That of HIV: Implications for Further Preclinical Drug Development (2008) (9)
CXCR7/ACKR3-targeting ligands interfere with X7 HIV-1 and HIV-2 entry and replication in human host cells (2018) (9)
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3′,4′,5′-trimethoxyphenyl)-3-(2′-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach (2018) (9)
A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury (2017) (9)
CXC-Chemokine Receptor 4 Is Not a Coreceptor for Human Herpesvirus 7 Entry into CD4+ T Cells (2000) (9)
Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis. (2021) (8)
Phosphonylated Acyclic Guanosine Analogues with the 1,2,3-Triazole Linker (2015) (8)
A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4. (2018) (8)
Acetate as a model for aspartate-based CXCR4 chemokine receptor binding of cobalt and nickel complexes of cross-bridged tetraazamacrocycles. (2019) (8)
A Novel Series of Indole Alkaloid Derivatives Inhibit Dengue and Zika Virus Infection by Interference with the Viral Replication Complex (2021) (8)
Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication. (2011) (8)
HIV-1 and Its Resistance to Peptidic Carbohydrate-Binding Agents (CBAs): An Overview (2014) (8)
Water-soluble fullerene-based nanostructures with promising antiviral and myogenic activity. (2020) (8)
Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors (2018) (8)
Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype. (2021) (8)
Susceptibility of diverse primary HIV isolates with varying co‐receptor specificity's to CXCR4 antagonistic compounds (2002) (8)
Virus-inhibitory peptide: a natural HIV entry inhibitor in search for a formal target in the viral genome. (2011) (8)
Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase. (2021) (8)
Inhibition of HIV-1-Induced Cytopathogenicity, Syncytium Formation, and Virus-Cell Binding by Naphthalenedisulphonic Acids through Interaction with the Viral Envelope gp120 Glycoprotein (1993) (8)
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model (2021) (8)
TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication. (1992) (7)
A patent review of adaptor associated kinase 1 (AAK1) inhibitors (2013-present) (2021) (7)
HIV-1 gp 120 and chemokines activate ion channels in primary macrophages through CCR 5 and CXCR 4 stimulation (2000) (7)
Improving potencies and properties of CD4 down-modulating CADA analogs (2012) (7)
Synthesis and Ativiral Activity of 5-(Benzylthio)-4-carbamyl-1,2,3-triazoles Against Human Cytomegalovirus (CMV) and Varicella-zoster Virus (VZV). (2017) (7)
Design, Synthesis, and the Biological Evaluation of a New Series of Acyclic 1,2,3‐Triazole Nucleosides (2017) (7)
Synthesis and Bioactivity of Novel Trisubstituted Triazole Nucleosides (2016) (7)
Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors. (2020) (7)
Iterative Chemical Engineering of Vancomycin Leads to Novel Vancomycin Analogs With a High in Vitro Therapeutic Index (2018) (7)
Promising anti-HIV therapeutic strategy with a small molecule CXCR4 antagonist. (1999) (7)
A unique class of lignin derivatives displays broad anti-HIV activity by interacting with the viral envelope. (2019) (7)
Membrane permeable, bioreversibly modified Prodrugs of Nucleoside Diphosphate-γ-phosphonates. (2020) (7)
Isoxazolidine Conjugates of N3-Substituted 6-Bromoquinazolinones—Synthesis, Anti-Varizella-Zoster Virus, and Anti-Cytomegalovirus Activity (2018) (7)
A Short Hairpin Loop-Structured Oligodeoxynucleotide Targeting the Virion-Associated RNase H of HIV Inhibits HIV Production in Cell Culture and in huPBL-SCID Mice (2011) (7)
Synthesis and Antiviral Activity of Water‐Soluble Polycarboxylic Derivatives of [60]Fullerene Loaded with 3,4‐Dichlorophenyl Units (2018) (7)
X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interaction. (2003) (7)
CXCR4 is the primary receptor for feline immunodeficiency virus in astrocytes (2001) (7)
Prodrugs of γ‐Alkyl‐Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase (2020) (7)
Coumermycin A1 is a potent inhibitor of human immunodeficiency virus (HIV) replication in vitro (1989) (7)
Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions (2020) (6)
Profound Anti-HIV-1 Activity of DAPTA in Monocytes/macrophages and Inhibition of CCR5-mediated Apoptosis in Neuronal Cells (2007) (6)
Innate Lymphoid Cells Are Required to Induce Airway Hyperreactivity in a Murine Neutrophilic Asthma Model (2022) (6)
Synthesis and Antiviral Evaluation of TriPPPro‐AbacavirTP, TriPPPro‐CarbovirTP, and Their 1′,2′‐cis‐Disubstituted Analogues (2018) (6)
Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization (2010) (6)
Restricted entry of R5 HIV Type 1 strains into eosinophilic cells. (2004) (6)
Inhibition of Human Immunodeficiency Virus Replication by a Dual CCR 5 / CXCR 4 Antagonist (2004) (6)
FO‐SPR biosensor calibrated with recombinant extracellular vesicles enables specific and sensitive detection directly in complex matrices (2021) (6)
Synthesis, Anti-varicella-zoster virus and Anti-cytomegalovirus Activity of 4,5-Disubstituted 1,2,3-(1H)-Triazoles. (2019) (6)
Combination of the CCL5-Derived Peptide R4.0 with Different HIV-1 Blockers Reveals Wide Target Compatibility and Synergic Cobinding to CCR5 (2014) (6)
Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus / CD 4 cell receptor ( acquired immunodeficiency syndrome / flow cytometry (6)
Design, synthesis, and cytostatic activity of novel pyrazine sorafenib analogs (2016) (6)
Discovery of ( ±)-3-(1 H -pyrazol-1-yl)-6,7-dihydro-5 H -[1,2,4]triazolo[3,4- b ][1,3,4] thiadiazine derivatives with promising in vitro anticoronavirus and antitumoral activity (2021) (6)
Resistance profile of human immunodeficiency virus to CADA, a novel HIV inhibitor that targets the cellular CD4 receptor (2005) (6)
Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 Replication. (2012) (6)
[Role of chemokines in the HIV infection process]. (2002) (6)
Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum (2019) (6)
Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro (1992) (6)
Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes (2021) (5)
A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide (2021) (5)
Synthesis and Evaluations of “1,4‐Triazolyl Combretacoumarins” and Desmethoxy Analogs (2019) (5)
Synthesis, characterization and anti-HIV activity of polycarboxylic [60]fullerene derivatives obtained in the reaction of C60Cl6 with a hydroquinone ether (2020) (5)
CXCR4 Chemokine Receptor Antagonists from Ultra-rigid Metal Complexes Profoundly Inhibit HIV-1 Replication, and also AMD3100-resistant Strains (2009) (5)
Multi-drug resistant HIV-1 is sensitive to inhibition by chemokine receptor antagonists (2005) (5)
Metal complexes of pyridine-fused macrocyclic polyamines targeting the chemokine receptor CXCR4. (2015) (5)
Synthesis of 2-[(ω-phthalimidoalkyl)sulfanyl]- pyrimidin-4(3H)-ones, their cytotoxicity and in vitro activity against HIV-1/2 (2020) (5)
Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replication. (2013) (5)
Sliding of HIV-1 reverse transcriptase over DNA creates a transient P pocket – targeting P-pocket by fragment screening (2021) (5)
Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors (2021) (5)
Novel isoxazolidine analogues of homonucleosides and homonucleotides (2016) (5)
In Vitro Characterization of the Carbohydrate-Binding Agents HHA, GNA, and UDA as Inhibitors of Influenza A and B Virus Replication (2020) (5)
Lipophilic Triphosphate Prodrugs of various Nucleoside Analogues. (2020) (5)
Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer (2021) (4)
Deciphering the Role of Extracellular Vesicles Derived from ZIKV-Infected hcMEC/D3 Cells on the Blood–Brain Barrier System (2021) (4)
Diastereoselective Synthesis of (1,3‐Dioxan‐4‐yl)pyrimidine and Purin Nucleoside Analogues (2015) (4)
Synthesis of Novel Thiopurine Pyranonucleosides: Evaluation of Their Bioactivity (2015) (4)
CADA, a Potential Anti-HIV Microbicide that Specifically Targets the Cellular CD4 Receptor (2009) (4)
New [4,5,1-JK][1,4]benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 and are synergistic with 2',3'-dideoxynucleoside analogs (1994) (4)
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators. (2018) (4)
Exploring the purine core of 3′-C-ethynyladenosine (EAdo) in search of novel nucleoside therapeutics (2016) (4)
Design, synthesis and antiviral evaluation of novel acyclic phosphonate nucleotide analogs with triazolo[4,5-b]pyridine, imidazo[4,5-b]pyridine and imidazo[4,5-b]pyridin-2(3H)-one systems (2020) (4)
Polyfunctionalized Pyrrole Derivatives: Easy Three-component Microwave-assisted Synthesis, Cytostatic and Antiviral Evaluation (2018) (4)
Double Arylation of the Indole Side Chain of Tri- and Tetrapodal Tryptophan Derivatives Renders Highly Potent HIV-1 and EV-A71 Entry Inhibitors (2021) (4)
Characterization of vertebrate peptide hormone-like materials in the American cockroach: different methods employed to investigate these substances and their results (1986) (4)
Correction: Facile functionalization at the C4 position of pyrimidine nucleosides via amide group activation with (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and biological evaluations of the products. (2017) (4)
Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a thiazolo[4,5-d]pyrimidine. (2022) (4)
Synthesis of Enantiomerically Pure 1′,2′-cis-dideoxy, -dideoxydidehydro, -ribo and -deoxy Carbocyclic Nucleoside Analogues (2018) (4)
Tryptophan Trimers and Tetramers Inhibit Dengue and Zika Virus Replication by Interfering with Viral Attachment Processes (2020) (4)
Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation in vivo and Anti-HIV-1 Activity (2018) (4)
Unsung Hero Robert C. Gallo (2009) (4)
CXCR4 Antagonists: A New Generation of Configurationally Restricted Bis-azamacrocyclic Compounds (2009) (4)
The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach. (2022) (4)
Phosphonylated 8-Azahypoxantines as Acyclic Nucleotide Analogs (2015) (3)
An easy microwave-assisted synthesis of C8-alkynyl adenine pyranonucleosides as novel cytotoxic antitumor agents (2015) (3)
Early protein expression profile in bronchoalveolar lavage fluid and clinical outcomes in primary graft dysfunction after lung transplantation. (2020) (3)
SARS-CoV-2 Virion Infectivity and Cytokine Production in Primary Human Airway Epithelial Cells (2022) (3)
Synthesis of Stilbene-Based Resveratrol Analogs as Cytotoxic Agents (2016) (3)
Water-Promoted Reaction of C60Ar5Cl Compounds with Thiophenes Delivers a Family of Multifunctional Fullerene Derivatives with Selective Antiviral Properties. (2021) (3)
Some Features of the Tscherniac‒Einhorn Reaction with 2-Thiouracil Derivatives (2020) (3)
Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane. (2021) (3)
The role of cytokines in transplantation tolerance (1995) (3)
Skeleton binding protein-1-mediated parasite sequestration inhibits spontaneous resolution of malaria-associated acute respiratory distress syndrome (2021) (3)
Synthesis and Anti‐HIV Activity of Guanine Modified Fluorinated Acyclic Nucleoside Phosphonate Derivatives (2019) (3)
Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action (2021) (3)
Synthesis, in silico ADME, molecular docking and in vitro cytotoxicity evaluation of stilbene linked 1,2,3-triazoles (2021) (3)
Itaconic acid hybrids as potential anticancer agents (2020) (3)
Synthesis, in vitro cytotoxicity, molecular docking and ADME study of some indolin-2-one linked 1, 2, 3-triazole derivatives (2022) (3)
CC Chemokine Receptor 3 Human Eotaxin by Affecting Its Interaction Potency , But Not the Anti-HIV Activity of Down-Regulates the Eosinophil Chemotactic CD 26 / Dipeptidyl-Peptidase IV (1999) (3)
Synthesis, Molecular Docking and Preliminary Antileukemic Activity of 4‐Methoxybenzyl Derivatives Bearing Imidazo[2,1‐b][1,3,4]thiadiazole (2020) (3)
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity (2022) (3)
Thiophene-based water-soluble fullerene derivatives as highly potent antiherpetic pharmaceuticals. (2020) (2)
Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases (2021) (2)
Virus resistance to the CXCR4 inhibitor AMD070 develops slowly and does not induce a co-receptor switch (2004) (2)
An efficient one-pot conversion of Boc-protected adenines to N-6-ureas (2015) (2)
Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication. (2011) (2)
Live biotherapeutic throat spray for respiratory virus inhibition and interferon pathway induction (2022) (2)
Chemotherapy of human immunodeficiency virus by pradimicin A: a novel therapeutic concept for treatment of glycosylated enveloped viruses (2006) (2)
Dual anti-HSV and anti-HIV activity of the lantibiotic Labyrinthopeptin A1 (2014) (2)
1H)-One and-Thione Derivatives ArePotent Inhibitors ofHuman Immunodeficiency Virus Type1Replication andAre Synergistic with2',3'-Dideoxynucleoside Analogs (1994) (2)
Carbohydrate-Binding Agents (CBAs) Selectively Target the Glycoproteins of the HCV and HIV Envelope to Prevent Viral Entry (2007) (2)
Selective inhibition of CD4 protein translocation and cell surface expression as a novel tool for preventing HIV infection (2010) (2)
In vitro synergy between the CD4 down-modulating compound, CADA, and multiple anti-HIV drugs (2003) (2)
In silico design, synthesis and anti-HIV activity of quinoline derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) (2022) (2)
VCH-286, a novel CCR5 antagonist: binding kinetics, anti-HIV activity and in vitro combination studies (2009) (2)
Erratum: Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetraacetyl esters (Molecular Pharmacology (2000) 58 (641-648)) (2001) (2)
Broad Antiviral Activity of Carbohydrate-Binding Agents Against Dengue Virus Infection (2012) (2)
Cellular receptors as targets for anti-human immunodeficiency virus agents (2001) (2)
Novel N-Substituted 3-Aryl-4-(diethoxyphosphoryl)azetidin-2-ones as Antibiotic Enhancers and Antiviral Agents in Search for a Successful Treatment of Complex Infections (2021) (2)
Copper-64 PET imaging of the CXCR4 chemokine receptor using a cross-bridged cyclam bis-tetraazamacrocyclic antagonist (2019) (2)
Synthesis, antiviral, cytotoxic and cytostatic evaluation of N1-(phosphonoalkyl)uracil derivatives (2016) (2)
Exploring the dNTP -binding site of HIV-1 reverse transcriptase for inhibitor design. (2021) (2)
Design, Synthesis, and Biological Evaluation of Novel C5-Modified Pyrimidine Ribofuranonucleosides as Potential Antitumor or/and Antiviral Agents. (2020) (2)
γ‐Non‐Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV (2020) (2)
Microvirin, a novel α(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has potent anti-HIV-1 activity (2010) (2)
Development of new potent and selective agents against HIV (human immunodeficiency virus). (1991) (2)
Synthesis and antiviral properties of new derivatives of 2-(alkylsulfanyl)-6-[1-(2,6-difluorophenyl)cyclopropyl]-5-methylpyrimidin-4(3H)-one (2016) (2)
HIV coreceptor CXCR4 antagonists (2006) (2)
Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model (2022) (2)
Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern (2022) (2)
SYNTHESIS OF IMIDAZO[2,1-b][1,3,4]THIADIAZOLE DERIVATIVES AS POSSIBLE BIOLOGICALLY ACTIVE AGENTS. (2016) (2)
Acyclic nucleoside phosphonates containing the amide bond (2016) (2)
Expedient synthesis and biological evaluation of alkenyl acyclic nucleoside phosphonate prodrugs (2018) (2)
Pradimicin S, a highly-soluble non-peptidic small-size carbohydrate-binding antibiotic, (2010) (2)
SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF IMIDAZO[2,1- b][1,3,4]THIADIAZOLE DERIVATIVES. (2016) (1)
Feglymycin, a Unique 13 Amino-acid Peptide, With a Novel Mechanism of Anti-HIV-1 Activity (2009) (1)
HIV-1 transcription in vivo-1-1 2 A NOVEL IN VIVO MODEL FOR THE STUDY OF HIV-1 3 TRANSCRIPTION INHIBITORS : EVALUATION OF NEW 4 6-DESFLUOROQUINOLONE DERIVATIVES ( 6-DFQs ) 5 6 7 (2007) (1)
A novel experimental porcine model to assess the impact of differential pulmonary blood flow on ischemia–reperfusion injury after unilateral lung transplantation (2020) (1)
Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists. (2021) (1)
Branched-chain sugar nucleosides: stereocontrolled synthesis and bioevaluation of novel 3'-C-trifluoromethyl and 3'-C-methyl pyranonucleosides. (2015) (1)
Different evolution and patterns of genotypic resistance profiles in emtricitabine plus tenofovir and lamivudine plus tenofovir containing regimen (2009) (1)
Interaction of TIBO and TIBO-like compounds with HIV-1 RT (1991) (1)
An Efficient One‐Pot Conversion of Boc‐Protected Adenines to N6‐Ureas. (2016) (1)
PRO 2000, a broadly active anti-HIV sulfonated compound, inhibits viral entry by multiple mechanisms (2010) (1)
Synergistic anti-HIV-1 activity of griffithsin with tenofovir, maraviroc and enfuvirtide (2011) (1)
In-Depth Characterization of Zika Virus Inhibitors Using Cell-Based Electrical Impedance (2022) (1)
Development and in vitro evaluation of gel-formulated saquinavir as vaginal microbicide: anti-HIV-1 activity and pharmaceutical availability in biorelevant media (2010) (1)
Design and synthesis of a new series of hybrids of functionalised N1-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus. (2022) (1)
Synthesis of Novel CADA Analog Prodrugs Designed as Down-Modulators of the CD4 Receptor (2010) (1)
CADA compounds: inhibitors of HIV and HHV-7 replication via down-modulation of CD4 receptor expression (2001) (1)
SRR-SB 3 , a Disulfide-Containing Macrolide That Inhibits a Late Stage of the Replicative Cycle of Human Immunodeficiency Virus (1997) (1)
Diffusion of Two Potential Anti-HIV Microbicides across Intact and De-Epithelialised, Human Vaginal Mucosa (2008) (1)
Potent and selective inhibition of HIV-1 and HIV-2 replication by a novel class of bicyclams targeted at viral uncoating (1992) (1)
Facile Microwave-assisted Synthesis of Various C5-modified Pyrimidine Pyranonucleosides as Potential Cytotoxic Antitumor Agents (2017) (1)
Heterocyclic compounds binding chemokine receptor with enhanced efficacy (2002) (1)
Mannose-specific plant lectins as potential HIV microbicides (2004) (1)
Development of a live biotherapeutic throat spray with lactobacilli targeting respiratory viral infections (2022) (1)
Synthesis and evaluation of 3-alkynyl-5-aryl-7-aza-indoles as broad-spectrum antiviral agents (2022) (1)
γ-Ketobenzyl-Modified Nucleoside Triphosphate Prodrugs as Potential Antivirals. (2020) (1)
POSTER VIEWING SESSION - ENDOMETRIOSIS, ENDOMETRIUM, IMPLANTATION AND FALLOPIAN TUBE (2011) (1)
Influence of initial conditions on the development of resistance to TIBO derivatives in cell culture (1992) (1)
NH2-terminal processing of chemokines (RANTES, SDF1-alpha) by CD26/dipeptidylpeptidase IV generates inhibitors of chemotaxis and HIV-1 infection (1998) (1)
Quantitative label-free nanoscale LC-MS analysis of HIV drug-treated human T-cell cultures (2006) (1)
A Set of Experimentally Validated Decoys for the Human CC Chemokine Receptor 7 (CCR7) Obtained by Virtual Screening (2022) (1)
Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope domain III (2013) (1)
Antiviral, cytostatic and cytotoxic activity of plant lectins in co-cultures of monocyte derived dendritic cells (MO-DC) and CD4+ T cells as representative target cells for sexual HIV transmission (2006) (1)
Endocrine-cells in the midgut of the cockroach periplaneta-americana l - an immunohistochemical study (1987) (1)
Cytotoxicity studies of primaquine and chloroquine fumardiamides (2019) (1)
Carbohydrate-binding agents (CBAs) potently inhibit HIV infection in human primary monocytes/macrophages and efficiently prevent viral capture and subsequent transmission to CD+4 T lymphocytes (2007) (1)
The Role of B-Cells in Phenotypes of Chronic Lung Allograft Dysfunction (2015) (1)
Palladium-catalyzed cross-coupling reactions on a bromo-naphthalene scaffold in the search for novel human CC chemokine receptor 8 (CCR8) antagonists. (2020) (1)
SYNTHESIS AND CYTOTOXIC EVALUATION OF SOME 2-{4-[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL] PHENOXY}-N-PHENYLACETAMIDE. (2017) (1)
Targeting chemokine receptors from the inside-out: discovery and development of small-molecule intracellular antagonists. (2022) (1)
1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes. (1991) (1)
Lignosulfonic acid exhibits broad-spectrum anti-HIV and anti-HSV activity and has potential for microbicidal applications (2014) (1)
Anti-HIV activity profile of a novel CCR5 inhibitor, AMD887, in combination with the CXCR4 inhibitor AMD070 (2004) (1)
Synthesis and Anti-HIV Activity of a Novel Series of Isoquinoline-Based CXCR4 Antagonists (2021) (1)
Synthesis, molecular docking, and preliminary cytotoxicity study of some novel 2-(naphthalen-1-yl)-methylimidazo[2,1-b][1,3,4]thiadiazoles (2021) (1)
Anthranilamides with quinoline and β-carboline scaffolds: design, synthesis, and biological activity (2022) (1)
Labyrinthopeptin A1, a novel lantibiotic peptide, is a dual HIV and HSV entry inhibitor (2013) (1)
Synthesis and structure-activity relationships of the novel isothiobarbamine analogues with lowered basicity (2020) (1)
A small-molecule inhibitor of CD4 protein translocation down-modulates the primary HIV receptor (2011) (1)
Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537] (2021) (1)
Acyclic nucleoside phosphonates containing the amide bond: hydroxy derivatives (2019) (1)
The Twenty-Second International Conference on Antiviral Research (2009) (1)
Antiviral activity of carbohydrate binding agents (CBAS) and the role of DC-SIGN in Dengue virus and HIV infection (2009) (1)
Mannose-specific plant lectins may qualify as efficient microbicides against human immunodeficiency virus transmission (2002) (1)
The orally bioavailable allosteric CXCR4 HIV-1 entry inhibitor AMD11070 (2012) (1)
Human T-cell development in SCID-hu mice (1995) (1)
D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy (2021) (1)
Potent and highly selective HIV-1 specific inhibition by a new series of alfa- anilino-phenylacetamide (alfa-APA) derivatives targeted at HIV-1 RT (1992) (1)
CADA inhibits HIV and HHV-7 replication by down-modulation of the cellular CD4 receptor (2001) (1)
Negatively charged albumins exhibit a potent invitro anti-HIV-1 activity and a unique inhibitory action on syncytium formation (1991) (0)
HIV-CD4 interaction as target for anti-HIV agents (1990) (0)
Insertion of an Amphipathic Linker in a Tetrapodal Tryptophan Derivative Leads to a Novel and Highly Potent Entry Inhibitor of Enterovirus A71 Clinical Isolates (2023) (0)
Preparation and Anti‐HIV Activity of O‐Acylated Heparin and Dermatan Sulfate Derivatives with Low Anticoagulant Effect. (2010) (0)
Evaluation of CXCR4 inhibitors by FLIPR and flow cytometric techniques (2002) (0)
The TIBO-site on HIV-1 reverse transcriptase represents a new target for anti-HIV chemotherapy (1991) (0)
In search of novel nucleoside therapeutics: exploring the purine core of 3'-C-ethynyladenosine (2015) (0)
Prevention of HIV transmission and SIV infection by specifically targeting CD4 (2008) (0)
Microvirin a novel carbohydrate binding lectin with potent anti-HIV-1 activity (2011) (0)
Interactions of the HIV fusion inhibitor AR177 (ZINTEVIR) with the HIV type I second receptor (1997) (0)
Triphosphate Prodrugs of the Anti-HIV-Active Compound 3'-Deoxy-3'-fluorothymidine (FLT). (2022) (0)
Synergistic activity of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 subtype C (2011) (0)
Development of new anti-HIV agents and elucidation of their mechanism of action (1990) (0)
Synthesis of CADA Analog Prodrugs Designed as Novel Down-modulators of the CD4 Receptor (2009) (0)
Brain and gastro-intestinal peptides of the vertebrate-type in the American cockroach Periplaneta americana L. Three complementary approaches (1986) (0)
Resistance development of human immunodeficiency virus by plant lectins from the Amaryllidaceae family (2003) (0)
Session 05: Endometriosis: Impact, Diagnosis and Surgery (2010) (0)
Design and cellular kinetics of dansyl-labeled CADA derivatives with specific anti-HIV and CD4 receptor down-modulating properties (2007) (0)
Itaconic acid hybrids as potential anticancer agents (2020) (0)
Receptor MDCChemokine ( MDC ) Imply an Additional-Terminally Processed Macrophage-Derived 2 and Altered Chemotactic Potency of NH Cutting Edge : Enhanced Anti-HIV-1 Activity (1998) (0)
Blockade of HIV transmission and SIV infection with CADA, a candidate microbicide that specifically targets the cellular CD4 receptor (2007) (0)
Evaluation of chemokine receptor antagonists: comparing FLIPR and flow cytometric techniques (2002) (0)
Chemotherapeutic targeting of the glycans on the viral envelope as a tool to prevent viral entry and transmission (2008) (0)
Mutagenic analysis of the preprotein signal sequence of the cellular HIV-1 receptor CD4, a unique target for CD4 down-modulating agents (2011) (0)
Abstracts of papers Symposium “new therapeutic developments in human infectious diseases” (1989) (0)
Synthesis of new riboflavin modified ODNs: Effect of riboflavin moiety on the G-quadruplex arrangement and stability. (2020) (0)
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation (2022) (0)
Carbohydrate-binding agents, but not polyanions efficiently prevent HIV-1 capture by DC-SIGN-expressing cells and subsequent virus transmission to CD4+ T-lymphocytes (2007) (0)
Anti-HIV Agents Interfering with the Viral gp120-Cellular CD4 Interaction (1992) (0)
Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model (2017) (0)
The live cell image JuLITM analyser as a useful tool for studying HIV cell-cell transmission (2012) (0)
The orally bioavailable allosteric CXCR4 HIV-1 entry inhibitor AMD11070 (2012) (0)
Triphosphate prodrugs (trippro's) of biologically active nucleosides (2015) (0)
[Lasting neurologic injury in therapeutic lithium plasma levels]. (1989) (0)
Potential chemotherapeutic targets in the replicative cycle of HIV (1994) (0)
Labyrinthopeptins - New lantibiotics with broad antiviral activity (2015) (0)
Effect of Head Group Variation on Human CD4 Down-Modulating and Anti-HIV Potencies of CADA Analogs (2014) (0)
Beta-arrestin 2 recruitment by GPCRs using NanoBiT and NanoBRET combined with FLIPR Tetra technology focusing on the G protein-independent chemokine receptor ACKR3/CXCR7 (2017) (0)
Flow cytometric/fluorometric assays for the evaluation of the anti-HIV activity of chemokine receptor inhibitors (2005) (0)
Broad-spectrum antiviral activity of polyoxometalates against human immunodeficiency virus and other enveloped viruses (1992) (0)
Co-translational translocation of human sortilin into the ER lumen is inhibited by cyclotriazadisulfonamide (2017) (0)
Novel synthesized compounds with ‘viologen’ skeleton have anti‐HIV‐1 activity and interfere with the HIV‐1 coreceptor CXCR4 (2011) (0)
Identification of angiogenic factors that mediate dengue virus-induced vascular permeability (2011) (0)
Bicyclams: selective CXCR4 antagonists with potent anti-HIV activity (1997) (0)
Peptide hormone immunocytochemistry in insects (1987) (0)
Effects of Sidearm Substituents in Unsymmetrical Cyclotriazadisulfonamide (CADA) Analogs on Anti-HIV and Human CD4 Down-Modulating Abilities (2014) (0)
Dansyl-tagged CADA derivatives with specific anti-HIV and CD4 receptor downmodulating properties (2007) (0)
Residues in the hydrophobic signal peptide region and charges at the amino-terminus of the mature human CD4 protein region contribute to CADA sensitivity (2016) (0)
A novel CD4 down-modulating compound with antiviral activity (2001) (0)
Synthesis of novel CADA analog prodrugs designed to act as anti-HIV agents via down-modulation of the CD4 receptor (2012) (0)
A small-molecule HIV entry inhibitor selectively inhibits co-translational translocation of CD4 into the endoplasmic reticulum (2013) (0)
Discovery of inhibitors for the human chemokine receptors CXCR4 and CXCR7: screening applications on the FLIPR Tetra high-throughput cellular screening system (2016) (0)
CADA, a novel antiretroviral drug with specific CD4 down-modulating activity (2002) (0)
Pentosan polysulfate in HIV patients: a phase I study (1990) (0)
Exploration of Pyrido[3,4-d]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2 (2023) (0)
The non-peptidic mannose-binding pradimycin antibiotics inhibit HIV infection, viral capture by DC-SIGN, and viral transmission to T-lymphocytes (2007) (0)
Cyclotriazadisulfonamide (CADA) compounds, HIV entry inhibitors that specifically target the cellular CD4 receptor (2006) (0)
HIV-1 integrase is transported to the nucleus when expressed as a fusion protein with GFP (1999) (0)
C-3’-ethynylnucleosides: an old modification going viral (2016) (0)
Purine-mimicking 3’-ethynylribofuranose nucleosides : new opportunities for an old sugar modification (2016) (0)
Pradimicin-S is a highly soluble non-peptidic small-size carbohydrate-binding antibiotic that may qualify as a potential drug lead for HIV treatment (2009) (0)
A Novel Small-molecule CCR5 Agonist, ESN-196, with Potent R5 HIV-1 Activity (2009) (0)
Resistance profile of human immunodeficiency virus to mannose-binding proteins (2004) (0)
Synthesis and anticancer activity of 6-aryl-2-naphthyl-imidazo[2,1 b][1,3,4]thiadiazole (2017) (0)
Synthesis of Anti-HIV CADA Compounds and Quantitative Structure-Activity Relationships for CD4 Down-Modulation (2003) (0)
Resistance development of human immunodeficiency virus type 1 towards mannose-specific plant lectins in cell culture (2003) (0)
Purification of natural CXCL12 – Characterisation of posttranslationally modified forms (2014) (0)
Citrullination of CXCL12 affects its inflammatory and anti-HIV-1 activity (2009) (0)
Natural CXCL12 nitration reduces its receptor signaling, chemotactic and anti-HIV activity (2014) (0)
CADA, a small-molecule HIV inhibitor, selectively inhibits co-translational translocation of the human CD4 receptor into the endoplasmic reticulum (ER) (2012) (0)
CAN WE ATTENUATE ISCHEMIA-REPERFUSION INJURY OF ALLOGRAFTS IN A PORCINE LEFT LUNG TRANSPLANT MODELS BY ADSORPTION OF CYTOKINES? (2022) (0)
CADA, a specific CD4 down-modulating compound with potent anti-HIV activity (2002) (0)
The anti-HIV and anti-HHV-7 potency of CADA analogs is strictly correlated with their ability to down-modulate the CD4 receptor (2002) (0)
Insights into biological activity of SAHAquines, hybrids based on SAHA and aminoquinoline motifs (2018) (0)
Signal peptide-binding drug inhibits cell surface CD4 receptor expression for HIV-1 attachment and entry (2014) (0)
Combination of the candidate microbicide CADA, an entry inhibitor that specifically targets the cellular CD4 receptor, and cellulose acetate 1,2-benzenedicarboxylate have synergistic effects against HIV infection (2006) (0)
Unsymmetrical CADA Analogs as Novel Down-modulators of the CD4 Receptor (2009) (0)
Development of novel therapeutic concepts and rational anti-HIV drug design (2006) (0)
Pradimicin antibiotics prevent HIV infection, viral capture by DC-SIGN and viral transmission to T-lymphocytes (2008) (0)
The anti-HIV prokaryotic lectin, cyanovirin-N (CV-N), but not several other lectins such as HHA, GNA and UDA induces activation and production of cytokines (2008) (0)
Visible-Light-Promoted Tandem Thiol-Ene Click Reaction/Transannular Cyclization and Regioselective Cyclopropane Ring-Opening to Construct Sulfur-Containing Euphorbia Diterpenes. (2023) (0)
In vitro evaluation of chloroquine gels against HIV-1 infection (2008) (0)
Optimizing the unsymmetrical structure of benzyl-tailed CADA analogs to improve their CD4 down-modulating and anti-HIV activity (2013) (0)
DC-SIGN: An important attachment receptor for dengue virus and for development of antiviral therapy with carbohydrate-binding agents (2010) (0)
GPCR cell-based fluorescence assays using the Fluorescence Imaging Plate Reader (FLIPR) Tetra (2015) (0)
Contents list. (2017) (0)
In vitro evaluation of gel-formulated saquinavir as vaginal microbicide: pharmaceutical availability in biorelevant media and anti-HIV-1 activity (2008) (0)
SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF IMIDAZO[2,1- b][1,3,4]THIADIAZOLE DERIVATIVES. (2016) (0)
TlBO derivatives : a new class of highly potent and specific inhibitors of HIV-I replication (2009) (0)
Griffithsin, in combination with all ARV drugs, potently inhibits HIV cellular transmission and destruction of target CD4 T cells (2013) (0)
Resistance profile of HIV-1 to the broadly neutralizing anti-gp120 2G12 antibody (2006) (0)
A new class of dual HIV and EV71 entry inhibitors: tri and tetrapodal tryptophan derivatives (2019) (0)
Switch in Coreceptor Use the Envelope gp120 but Does Not Show a Contains Mutations in α Cell-Derived Factor 1 Virus Type 1 That Is Made Resistant to Stromal T-Cell-Line-Tropic Human Immunodeficiency (2013) (0)
Targeted disruption of pi–pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity (2021) (0)
Vertebrate-type brain and gastrointestinal peptides in periplaneta, sarcophaga, locusta and crangon - the immunocytochemical approach (1986) (0)
Targeting the dengue virus envelope protein by Escherichia coli K5 derivatives to inhibit the infection of microvascular endothelial cells (2013) (0)
Cryo-EM structures of wild-type and E138K/M184I mutant HIV-1 RT/DNA complexed with inhibitors doravirine and rilpivirine (2022) (0)
Potent and highly selective HIV-1 specific inhibition by a new series of phenylacetamide derivatives targeted at HIV-1 RT (1992) (0)
Long-Lasting Enfuvirtide Carrier Pentasaccharide Conjugates with Potent Anti-Human Immunodeﬁciency Virus Type 1 Activity (cid:1) (2009) (0)
The non-peptidic carbohydrate-binding pradimycin antibiotics inhibit HIV infection, viral capture by DC-SIGN, and viral transmission and thus may qualify as potential microbicide candidate drugs (2008) (0)
Proﬁle of Resistance of Human Immunodeﬁciency Virus to Mannose-Speciﬁc Plant Lectins (2004) (0)
Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism (2022) (0)
Anti-HIV macrocyclic polyamines targeting cellular chemokine receptors CXCR4 and CCR5 (2009) (0)
A regioselective step-by-step C60Cl6 functionalization approach affords a novel family of C60Ar5Th'Th''H fullerene derivatives with promising antiviral properties. (2023) (0)
Proopiomelanocortin-related substances and a crf-like peptide in the midgut of the cockroach, periplaneta-americana (1987) (0)
Synthesis and quantitative structure-activity relationships of CADA compounds having anti-HIV and CD4 down-modulation activities (2005) (0)
In vitro resistance development of human immunodeficiency virus type 1 towards mannose-specific plant lectins (2003) (0)
Correlation between the anti-HIV potency of CADA derivatives and their ability to down-modulate the CD4 receptor (2002) (0)
Broad-spectrum anti-HIV activity of griffithsin and synergy with the antiretroviral drugs maraviroc, tenofovir and raltegravir (2012) (0)
ALBUMIN CAN BE MODIFIED TO AN EXTREMELY POTENT INHIBITOR OF HIV REPLICATION WITH SPECIFIC EFFECTS ON LYMPHOCYTE-T4-VIRUS FUSION AND SYNCYTIUM FORMATION (1991) (0)
CXCR4 and ACKR3 binding azamacrocyclic compounds for targeted PET imaging and therapeutic applications in cancer. (2019) (0)
Human Immunodeﬁciency Virus Type 1 Escape from Cyclotriazadisulfonamide-Induced CD4-Targeted Entry Inhibition Is Associated with Increased Neutralizing Antibody Susceptibility (cid:1) (2009) (0)
Immunological Overlap Between Rejection and Infection in Murine Lung Transplantation (2023) (0)
CXCR 4 chemokine receptor antagonists : nickel ( II ) complexes of con fi gurationally restricted macrocycles † (2012) (0)
Synthesis, anti-HIV and CD4 down-modulation activities of novel CADA compounds (2007) (0)
Macrocyclic Polyamines Targeting the Cellular HIV Co-receptors, CXCR4 and CCR5 (2009) (0)
TIBO derivatives represent a new lead of potent and selective HIV-1 inhibitors that interact with a reverse transcriptase-associated process (1990) (0)
Identification of chlorocarbazole derivatives as potential antiviral agents. (2018) (0)
Plant lectins are carbohydrate-binding agents that qualify as potential microbicide drugs (2006) (0)
Organotropic dendrons with high potency as HIV-1, HIV-2 and EV-A71 cell entry inhibitors. (2022) (0)
The anti-HIV activity of the CXCR4 inhibitor AMD3100 is independent of the CXCR4/HIV coreceptor level (2003) (0)
Mac-1+ cells as effector cells in the collagen-induced arthritis in IFN-gamma receptor knockout and wild-type mice (2003) (0)
CXCR4 antagonists as HIV entry inhibitors (2001) (0)
FLUIDOT: A Modular Microfluidic Platform for Single‐Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining (2023) (0)
PRO 2000, a broadly active anti-HIV sulfonated compound, inhibits HIV infection by multiple mechanisms (2009) (0)
229: Dengue virus infection and induction of proinflammatory cytokines in dendritic cells is profoundly inhibited by selective carbohydrate-binding agents (CBAs) (2013) (0)
Simultaneous inhibition of human CD4 and 4-1BB biogenesis suppresses cytotoxic T lymphocyte proliferation (2021) (0)
Correlation between side arm dipole moments and human CD4 down-modulating abilities in unsymmetrical cyclotriazadisulfonamide (CADA) compounds with anti-HIV activities (2015) (0)
Glycopeptide antibiotic derivatives selectively inhibit human immunodeficiency virus replication in cell culture (2003) (0)
Cytostatic activity of pyrazine sorafenib analogues (2015) (0)
Inhibition of autoimmune joint inflammation in mice by an antagonist of the SDF-1 chemokine receptor CXCR4 (2002) (0)
Anti-HIV activity profile of a highly specific CD4 receptor down-modulating compound (2003) (0)
heterocyclic compounds that bind to chemokine receptors and exhibit improved efficacy (2004) (0)
A Novel Experimental Porcine Model to Assess the Impact of Differential Pulmonary Blood Flow on Primary Graft Dysfunction After Unilateral Lung Transplantation (2020) (0)
Synthesis, Molecular Docking and Molecular Dynamics Simulation of 2-thioxothiazolidin-4-one derivatives against Gp41. (2020) (0)
The candidate sulfonated microbicide, PRO 2000, has multiple mechanisms of antiviral action (2008) (0)
Exposure of Raji / DC-SIGN cells to HIV-1 and subsequent cocultivation with CD 4 1 C 8166 cells in the presence of OAA and OPA (2014) (0)
Potent and highly selective HIV-1 specific inhibition by a new series of alfa-anilino phenyl acetamide (alfa-APA) derivatives targeted at HIV-1 reverse transcriptase (1992) (0)
Cell-Based Electrical Impedance Platform to Evaluate Zika Virus Inhibitors in Real Time. (2023) (0)
135 Safety Concerns for Cyanovirin as a Microbicidal Anti-HIV Agent (2007) (0)
Synthesis of Unsymmetrical Cyclotriazadisulfonamide (CADA) Analogs as Human CD4 Down-Modulating Antivirals (2014) (0)
Small molecule receptor inhibitors as a novel strategy for the inhibition of human immunodeficiency virus (HIV) infection (2006) (0)
A second-generation of tryptophan-containing small molecules extremely potent against HIV and EV-A71 clinical isolates (2019) (0)
Synthesis of electron-rich cyclotriazadisulfonamide (CADA) analogs as anti-HIV and human CD4 receptor down-modulating agents (2013) (0)
In vitro evaluation of chloroquine as a microbicide candidate against HIV infection (2007) (0)
Blockade of SIV and HIV infection with CADA, a novel entry inhibitor that specifically targets the cellular CD4 receptor (2005) (0)
Anti-HIV activity and CD4 receptor down-modulating effect of cyclotriazadisulfonamide (CADA) structural analogs (2014) (0)
Metal complexes of macrocyclic polyamines targeting the cellular HIV co-receptors, CXCR4 and CCR5 (2010) (0)
The candidate microbicide CADA, an entry inhibitor that specifically targets the cellular CD4 receptor, prevents HIV and SIV infection of human and simian cells (2006) (0)
Differential activity of candidate microbicide molecules against human immunodeficiency virus upon complement virus opsonization (2006) (0)
Pharmaceutical performance of vaginal microbicide gels for the poorly water-soluble saquinavir in biorelevant media (2008) (0)
Synthesis of novel N-acyl-β-d-glucopyranosylamines and ureas as potential lead cytostatic agents (2016) (0)
Feglymycin, a unique natural bacterial peptide isolated from Streptomyces sp. DSM11171, potently inhibits HIV replication by interfering with the CD4/gp120 interaction (2012) (0)
Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is suitable for high-throughput evaluation of HIV/coreceptor inhibitors (2004) (0)
A stabilized CXCL9(74-103)-derived peptide selectively inhibits proliferation, adhesion and metastasis of tumor cells that express high levels of heparan sulfate. (2022) (0)
Design, synthesis, and cytostatic activity of novel pyrazine sorafenib analogs (2016) (0)
Naphthalenedisulfonic acid derivatives inhibit HIV-1-induced cytopathogenesis, syncytia formation and virus-cell binding by interaction with the viral envelope glycoprotein (1993) (0)
Progress in the study of vertebrate-type neuropeptides in Locusta, Periplaneta and Sarcophaga (1986) (0)
CXCL12/ALEXA FLUOR 647 : a novel, non-radioactive probe for flow cytometric evaluation of CXCR4 inhibitors (2004) (0)
Synthesis of novel thioalkylated triazolothiazoles and their promising in-vitro antiviral activity (2023) (0)
Corrigendum: Innate lymphoid cells are required to induce airway hyperreactivity in a murine neutrophilic asthma model (2022) (0)
HIV-1 mutational pathways, resistance profile and potential side effects of cyanovirin (2006) (0)
High affinity novel CXCR4 antagonists radiolabelled with copper-67 and gallium-68 for theragnostic applications (2022) (0)
CADA, a specific down-modulator of the primary HIV receptor, acts as a small-molecule inhibitor of CD4 protein translocation into the ER (2012) (0)
Brussel Lectin-Glycan Interaction Network-Based Identification of Host Receptors of Microbial Pathogenic (2016) (0)
Human immunodeficiency virus gp120 as the primary target of action of AR177 (Zintevir) (1997) (0)
Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors (2022) (0)
Mannose-specific lectins as novel microbicides against HIV (2003) (0)
The lantibiotic, labyrinthopeptin A1, demonstrates a broad and unique anti-HIV activity profile (2015) (0)
P.3.18 Early course of schizophrenic disorders;results from a Dutch epidemiological study (2005) (0)
Cyclotriazadisulfonamide prevents HIV transmission and SIV infection by specifically targeting the cellular CD4 receptor (2008) (0)
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants (2022) (0)
Modified proteins and their use for the control of viral infections (1992) (0)
A novel class of HIV inhibitors that target the cellular CD4 receptor (2004) (0)
Disulfide-containing macrolides that inhibit a late stage of the replicative cycle of human immunodeficiency virus (1997) (0)
Cryo-EM structures of Doravirine and Rilpivirine with HIV-1 Reverse Transcriptase/DNA Aptamer – Nonnucleoside Inhibitor Resistance by E138K and M184I Mutations (2022) (0)
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice (2018) (0)
HIV-1 resistance towards CADA-induced CD4 receptor-targeted inhibition is associated with increased sensitivity to neutralizing antibodies (2008) (0)
Synthesis of novel CADA compounds and their anti-HIV and CD4 down-modulation activities (2004) (0)
The role of DC-SIGN in HIV and dengue virus transmission and infection (2008) (0)
Heterociclical compounds that join chemiokin receptors. (2000) (0)
HIV-1 strains resistant to mannose- and N-acetylglucosamine-binding proteins show mutations at glycosylation sites of gp120 (2005) (0)
Chemokine receptor antagonists as HIV entry inhibitors (2004) (0)
Carbohydrate binding agents (CBA) cause the deletion of highly conserved glycosylation sites in the HIV-1 gp120 envelope (2005) (0)
Cyclotriazadisulfonamide compounds prevent HIV infection of macrophages and dendritic cells by specifically targeting the cellular CD4 receptor (2009) (0)
Consistent antiviral activity of carbohydrate-binding agents against the 4 different serotypes of dengue virus (2009) (0)
Macrocyclic polyamines inhibit HIV infection by interacting with the cellular HIV co-receptors CXCR4 and CCR5 (2009) (0)
The HIV entry inhibitor CADA selectively inhibits CD4 protein translocation: a novel approach for regulating the expression of the cellular HIV receptor (2010) (0)
Design, Synthesis, Anti-Varicella-Zoster and Antimicrobial Activity of (Isoxazolidin-3-yl)Phosphonate Conjugates of N1-Functionalised Quinazoline-2,4-Diones (2022) (0)
CADA compounds: potent CD4-targeted HIV inhibitors (2004) (0)
Acyclic/Carbocyclic Guanosine Analogues as Anti‐Herpesvirus Agents (2001) (0)
HIV-1 specific phenylacetamide derivatives: a novel class of reverse transcriptase inhibitors with potent and selective antiviral activity in vitro (1992) (0)
The potential role of innate lymphoid cells in non-allergic neutrophilic asthma model (2022) (0)
in 1 vitro Zika virus replication and delays disease progression in a robust mouse infection model 2 3 Running Title : Inhibition of Zika virus replication (2016) (0)
Differential inhibition of R5-HIV-1 adsorption on epithelial HEC-1 cells, macrophages and dendritic cells, and HIV-1 transcytosis through polarized HEC-1 monolayer by mannose-specific plant lectins (2006) (0)
Biological activity of novel primaquine-cinnamic acid conjugates of the amide type (2017) (0)
Author response for "Pre‐protein signature for full susceptibility to the co‐translational translocation inhibitor cyclotriazadisulfonamide (CADA)" (2019) (0)
Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model (2022) (0)
Optimization of triazolo[4,5-d]pyrimidines towards human CC chemokine receptor 7 (CCR7) antagonists. (2023) (0)
Decreased Ring Size in Cyclotriazadisulfonamide (CADA) Analogs with Preserved CD4 Down-Modulating and anti-HIV Activity (2014) (0)
Introduction to the Special Issue dedicated to Prof. Erik De Clercq for reaching the Professor Emeritus status at the Katholieke Universiteit Leuven (2006) (0)
Treatment of collagen-induced arthritis (CIA) in IFN-gammaR knock-out and wild-type mice with a specific CXCR4 inhibitor exposes different pathways in the pathogenesis of the disease (2003) (0)
2 A NOVEL IN VIVO MODEL FOR THE STUDY OF HIV-1 3 TRANSCRIPTION INHIBITORS : EVALUATION OF NEW 4 6-DESFLUOROQUINOLONE DERIVATIVES ( 6-DFQs ) 5 (2007) (0)
Carbohydrate-Binding Agents (CBA) inhibit entry of the human immunodeficiency virus (HIV) into its target cells through binding on the glycans of the viral envelope gp120 (2006) (0)
CD4 down-modulating activity of cyclotriazadisulfonamide (CADA) analogs correlates with their anti-HIV potency (2013) (0)
Drug-induced inhibition of co-translational translocation of human CD4 into the endoplasmic reticulum (ER) (2013) (0)
AMD3100, a potent and specific CXCR4 antagonist, inhibits autoimmune joint inflammation in mice (2001) (0)
Dengue virus infection of human microvascular endothelial cells is inhibited by sulfated Escherichia coli K5 polysaccharide derivatives (2012) (0)
Anti-HIV-1 activity and pharmaceutical availability in biorelevant media of gel-formulated saquinavir as a vaginal microbicide (2010) (0)
Virulence Evolves In Vivo , Leading to Increased Immunodeficiency Virus with Nef Deleted Coreceptor Phenotype of Natural Human (2002) (0)
Synthesis of novel N-acyl-β-d-glucopyranosylamines and ureas as potential lead cytostatic agents (2016) (0)
Biological activity of novel primaquine-cinnamic acid conjugates of the acylsemicarbazide type (2017) (0)
The candidate microbicide CADA prevents HIV transmission and SIV infection by specifically targeting the cellular CD4 receptor (2007) (0)
Specific CD4 down-modulating compounds with potent anti-HIV and HHV-7 activity (2002) (0)
Development of new cyclotriazadisulfonamide (CADA) analogs that inhibit HIV replication by down-modulation of the CD4 receptor (2013) (0)
Cobinding to CCR5 Wide Target Compatibility and Synergic R4.0 with Different HIV-1 Blockers Reveals Combination of the CCL5-Derived Peptide (2014) (0)
Effect of Molecular Symmetry on Potency in Novel Down-Modulators of the CD4 Receptor (2011) (0)
Flow-cytometric evaluation of chemokine-induced Transwell cell migration (2003) (0)
Griffithsin, a lectin isolated from Griffithsia sp. is endowed with potent and broad spectrum anti-HIV activity and has an outstanding safety profile (2012) (0)
β-lactam analogs of oxetanocins – synthesis and biological activity (2022) (0)
Griffithsin/CBA combinations demonstrate superior activity against HIV‐1, HIV‐2 and even against CBA‐resistant HIV‐1 strains (2011) (0)
New 2-alkylthio-1-benzylimidazole-5-carboxylic acid derivatives targeting gp41: design, synthesis and in vitro anti-HIV activity evaluation. (2022) (0)
Sugar-binding proteins potently inhibit HIV-1 infection of dendritic cells and dendritic cell-directed HIV-1 transfer (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dominique Schols?

Dominique Schols is affiliated with the following schools:

Dominique Schols's Academic­Influence.com Rankings

Dominique Schols's Degrees

Similar Degrees You Can Earn

Why Is Dominique Schols Influential?

Dominique Schols's Published Works

Published Works

What Schools Are Affiliated With Dominique Schols?

Dominique Schols's AcademicInfluence.com Rankings